I am pleased to introduce the latest article, “A Closer Look At Redefining Charcot,” in our CE series. This series, brought to you by the North American Center for Continuing Medical Education (NACCME), consists of regular CE activities that qualify for one continuing education contact hour (.1 CEU). Readers will not be required to pay a processing fee for this course.
The standard of care for Charcot neuroarthropathy is “largely ill defined,” according to Molly Judge, DPM. Accordingly, Dr. Judge reviews the literature on this subject, emphasizing an understanding of the etiology of the disease process, and its potential ramifications in terms of degenerative changes, altered pathomechanics and musculoskeletal issues.
At the end of this article, you’ll find a nine-question exam. Please mark your responses on the enclosed postcard and return it to NACCME. This course will be posted on Podiatry Today’s Web site (www.podiatrytoday.com) roughly one month after the publication date. I hope this CE series contributes to your clinical skills.
Jeff A. Hall
INSTRUCTIONS: Physicians may receive one continuing education contact hour (.1 CEU) by reading the article on pg. 108 and successfully answering the questions on pg. 114. Use the enclosed card provided to submit your answers or log on to www.podiatrytoday.com and respond via fax to (610) 560-0502.
ACCREDITATION: NACCME is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine.
DESIGNATION: This activity is approved for 1 continuing education contact hour or .1 CEU.
DISCLOSURE POLICY: All faculty participating in Continuing Education programs sponsored by NACCME are expected to disclose to the audience any real or apparent conflicts of interest related to the content of their presentation.
DISCLOSURE STATEMENTS: Dr. Judge has disclosed that she has no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of her presentation.
GRADING: Answers to the CE exam will be graded by NACCME. Within 60 days, you will be advised that you have passed or failed the exam. A score of 70 percent or above will comprise a passing grade. A certificate will be awarded to participants who successfully complete the exam.
TARGET AUDIENCE: Podiatrists
RELEASE DATE: August 2006
EXPIRATION DATE: August 31, 2007
LEARNING OBJECTIVES: At the conclusion of this activity, participants should be able to:
• discuss the findings from Elosser’s study and criticisms of the study;
• review the potential effects of nerve damage on bone healing;
• describe how anesthetic joint pathomechanics impact Charcot neuroarthropathy;
• review key musculoskeletal factors involved with Charcot neuroarthropathy; and
• discuss key characteristics of hypertrophic and atrophic bone destruction in neuropathic joints.
Sponsored by the North American Center for Continuing Medical Education.